suggest we are now starting to hear the full story:
can't see any licence agreements before July until ARUP has worked out the figures and probably some time after given a review period
Kos seems to be taking over at the top. Cons appointment ends in May.
may see some shuffling of board in the short term, but actual revenue by the company is some time away. the underlying problem will be cash burn and available dollars - the half yearly showed they had <$400,000
- Forums
- ASX - By Stock
- ECT
- no reaction to news
no reaction to news
Featured News
Add ECT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.343M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $483 | 241.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 5284426 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 15149396 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 5284426 | 0.002 |
28 | 36456532 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 15149396 | 23 |
0.004 | 7303519 | 10 |
0.005 | 3296859 | 21 |
0.006 | 3178567 | 7 |
0.007 | 918333 | 2 |
Last trade - 10.02am 18/11/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online